Mysthera Therapeutics AG
PrivateLast Round
Seed
Aug 21, 2023
Total Funding Raised
$3.5M
Company Overview
Mysthera Therapeutics AG is a biotechnology company that develops first-in-class, oral therapeutics for the treatment of complex autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mysthera Therapeutics AG Comparables
Compare Mysthera Therapeutics AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EydisBio, Inc. | 78% | |
| Shionogi & Co. | 71% | |
| Eli Lilly and Company | 71% |
Mysthera Therapeutics AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 21, 2023 |
Mysthera Therapeutics AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forty51 Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2023
$4M round led by Forty51 Ventures
Mysthera Therapeutics AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mysthera Therapeutics AG's valuation, stock price, and market status.
Is Mysthera Therapeutics AG a public or private company?
Mysthera Therapeutics AG is a private company.
What is the current stock price of Mysthera Therapeutics AG?
Mysthera Therapeutics AG is a private company with no public stock price. Caplight tracks Mysthera Therapeutics AG's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Mysthera Therapeutics AG worth (valuation)?
Valuation information for Mysthera Therapeutics AG is not publicly available.
Can I buy Mysthera Therapeutics AG stock?
Mysthera Therapeutics AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Mysthera Therapeutics AG's last funding round?
Mysthera Therapeutics AG's most recent funding round was Seed on August 21, 2023.
Who are the main investors in Mysthera Therapeutics AG?
Key investors in Mysthera Therapeutics AG include Forty51 Ventures.
Will Mysthera Therapeutics AG IPO soon?
No public IPO plans have been announced for Mysthera Therapeutics AG.
How can I track Mysthera Therapeutics AG secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mysthera Therapeutics AG's secondary market activity and sign up for updates.